139 related articles for article (PubMed ID: 16620491)
1. Polycystic ovary syndrome.
Al-Inany H
Clin Evid; 2005 Dec; (14):2343-51. PubMed ID: 16620491
[No Abstract] [Full Text] [Related]
2. Polycystic ovary syndrome.
Al-Inany H
Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
[No Abstract] [Full Text] [Related]
3. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
[TBL] [Abstract][Full Text] [Related]
4. [Combined use of metformin and Diane35 in polycystic ovary syndrome].
Mitkov M; Pekhlivanov B; Terzieva D
Akush Ginekol (Sofiia); 2004; 43(3):34-7. PubMed ID: 15341255
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
[TBL] [Abstract][Full Text] [Related]
6. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
[TBL] [Abstract][Full Text] [Related]
7. [Antiandrogen therapy in the polycystic ovary syndrome].
Messina M; Milani P; Gentile L; Gellona A; Monaco A; Manieri C
Minerva Endocrinol; 1987; 12(3):231-8. PubMed ID: 3657744
[No Abstract] [Full Text] [Related]
8. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
10. Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
Makedos A; Goulis DG; Papanikolaou A; Panidis D
Angiology; 2010 Aug; 61(6):595-601. PubMed ID: 20395229
[TBL] [Abstract][Full Text] [Related]
11. How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Diamanti-Kandarakis E
J Endocrinol Invest; 1998 Oct; 21(9):623-9. PubMed ID: 9856417
[No Abstract] [Full Text] [Related]
12. Antiandrogen treatment of polycystic ovary syndrome.
Rittmaster RS
Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
[TBL] [Abstract][Full Text] [Related]
13. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
14. Hirsutism - from diagnosis to use of antiandrogens.
Unluhizarci K; Karaca Z; Kelestimur F
Front Horm Res; 2013; 40():103-14. PubMed ID: 24002408
[TBL] [Abstract][Full Text] [Related]
15. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Franks S; Layton A; Glasier A
Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
[TBL] [Abstract][Full Text] [Related]
16. The effect of ethinylestradiol (EE)/cyproterone acetate (CA) and EE/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS).
Bilgir O; Kebapcilar L; Taner C; Bilgir F; Kebapcilar A; Bozkaya G; Yildiz Y; Yuksel A; Sari I
Intern Med; 2009; 48(14):1193-9. PubMed ID: 19602786
[TBL] [Abstract][Full Text] [Related]
17. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Gul OB; Somunkiran A; Yucel O; Demirci F; Ozdemir I
Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
[TBL] [Abstract][Full Text] [Related]
18. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Luque-Ramírez M; Alvarez-Blasco F; Botella-Carretero JI; Sanchón R; San Millán JL; Escobar-Morreale HF
Diabetes Care; 2007 Sep; 30(9):2309-13. PubMed ID: 17536071
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Zemtsov A; Wilson L
Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
[No Abstract] [Full Text] [Related]
20. LHRH analogues and PCO disease: validity of the use of enantone depot in the treatment of the disease.
Vitale F; Ruggieri P
Acta Eur Fertil; 1992; 23(6):293-5. PubMed ID: 1343754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
